Your Dividend Strategy Is Quietly Costing You Hundreds of Thousands (Highlights)

Ari Gutman is a Wall Street contributor and host of Masters of the Market, a podcast dedicated to sharing the stories of everyday people who have built real wealth from nothing. In this conversation he breaks down why chasing passive income through dividends while you are young is quietly costing you hundreds of thousands of dollars, why volatile and risky are not the same thing and confusing the two is keeping you out of the best opportunities, and why there has never been an easier time to build real wealth even though most people are still making excuses for why they cannot start.Recorded March 12, 2026Watch Part 2: https://youtu.be/PmXca5oHc3ATimestamps:01:46 Meet Ari Gutman04:51 The most powerful wealth building story Ari has ever heard06:12 Why classifying yourself as any type of investor is a mistake10:56 Where to actually start if you have never invested before15:21 What dividends actually are and why they sound better than they are18:40 Why the FIRE movement will leave you disappointed22:43 Why AI makes growth investing more important than ever26:18 Growth vs income the institutional way of thinking about it32:56 Where Ari actually gets his investment ideas38:17 The shameless cloning strategy that made Monish Pabrai a legend44:22 The legitimate zero to one for complete beginners48:38 Why leverage is more dangerous than most people realize52:01 The three levers of investing success and which one actually matters53:07 Why patience is the hardest skill in investing and how to build itDisclaimer This video is for education and entertainment only. We are not financial, legal, tax, or investment advisors. Nothing here is a recommendation or a solicitation to buy/sell any asset or strategy. Crypto and markets are risky—you can lose all your money. Do your own research and consult a qualified professional.We (and guests) may hold positions in assets discussed and may receive sponsorships/affiliate revenue from links—assume we do. Mention of any company, protocol, or product is not an endorsement. Information may be inaccurate, incomplete, or outdated as of recording. Past performance is not indicative of future results.